- Home
- SPCB vs LGVN Comparison
SPCB vs LGVN Comparison
Compare SPCB & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCB
- LGVN
- Stock Information
- Founded
- SPCB 1988
- LGVN 2014
- Country
- SPCB Israel
- LGVN United States
- Employees
- SPCB N/A
- LGVN N/A
- Industry
- SPCB Semiconductors
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- SPCB Technology
- LGVN Health Care
- Exchange
- SPCB Nasdaq
- LGVN Nasdaq
- Market Cap
- SPCB 31.4M
- LGVN 25.2M
- IPO Year
- SPCB N/A
- LGVN 2021
- Fundamental
- Price
- SPCB $10.77
- LGVN $1.56
- Analyst Decision
- SPCB Strong Buy
- LGVN Strong Buy
- Analyst Count
- SPCB 1
- LGVN 3
- Target Price
- SPCB $18.00
- LGVN $8.67
- AVG Volume (30 Days)
- SPCB 407.6K
- LGVN 161.2K
- Earning Date
- SPCB 11-14-2024
- LGVN 02-28-2025
- Dividend Yield
- SPCB N/A
- LGVN N/A
- EPS Growth
- SPCB N/A
- LGVN N/A
- EPS
- SPCB 1.02
- LGVN N/A
- Revenue
- SPCB $26,843,000.00
- LGVN $1,852,000.00
- Revenue This Year
- SPCB $6.72
- LGVN $208.32
- Revenue Next Year
- SPCB $16.91
- LGVN $43.96
- P/E Ratio
- SPCB $11.06
- LGVN N/A
- Revenue Growth
- SPCB 5.23
- LGVN 141.46
- 52 Week Low
- SPCB $2.55
- LGVN $0.77
- 52 Week High
- SPCB $18.95
- LGVN $6.40
- Technical
- Relative Strength Index (RSI)
- SPCB 51.88
- LGVN 45.58
- Support Level
- SPCB $10.50
- LGVN $1.53
- Resistance Level
- SPCB $13.69
- LGVN $1.71
- Average True Range (ATR)
- SPCB 1.25
- LGVN 0.13
- MACD
- SPCB -0.17
- LGVN 0.02
- Stochastic Oscillator
- SPCB 41.25
- LGVN 38.30
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.